Instead, Folx is designed to give control back to its members, allowing them to make informed decisions about their bodies and future at an affordable price. Even after all that, meds can be changed at the pharmacy without consent, and patients may wind up paying high costs anyway due to high co-pays and deductibles. Much of this kind of care isn’t covered, and, when it is, it requires an elaborate pre-approval process and bureaucratic barriers. Related on Built in Colorado Plume’s Early Success Is a Lesson in Tech Inclusivityīreitenstein says insurance compounds the problem. Add to that, the fact that many doctors won’t prescribe the medications we need, don’t understand our bodies, and if they do, they require many layers of unnecessary gatekeeping.” “The current system is confusing, expensive and discriminatory. “The current healthcare system is focused on diagnosing and treating, but for those in the trans and queer community, this is not always the case,” Breitenstein told Built In via email. Breitenstein has been working in this space for 30 years, starting in the height of the HIV/AIDS epidemic in the early ’90s, and in that time realized that the healthcare industry is “broken,” saying that many trans women face abuse from the industry and that one in five trans people are refused care completely. Investors include Define Ventures, Bessemer Venture Partners and Polaris Partners.įolx’s founder and CEO A.G. Folx Health, a Boston startup that is dedicated to providing accessible healthcare to the transgender and queer community, launched Thursday with a $4.4 million seed round.
0 Comments
Leave a Reply. |